Author details

Full Name

Julia B Lewis

Affiliation

Vanderbilt University Medical Center

ORCID

Career Start Year

1988

Papers

170

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37657637	Impact of Using the Race-Free 2021 CKD-EPI Creatinine Equation on Treatment Effects on GFR-Based End Points in Clinical Trials.	Am J Kidney Dis	2024
36918388	Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD.	J Am Soc Nephrol	2023
37558385	Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF.	JACC Heart Fail	2023
36754007	Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD.	Clin J Am Soc Nephrol	2023
36723299	Social Determinants of Health and Their Impact on the Black Race Coefficient in Serum Creatinine-Based Estimation of GFR: Secondary Analysis of MDRD and CRIC Studies.	Clin J Am Soc Nephrol	2023
34403831	Multinephron Segment Diuretic Therapy to Overcome Diuretic Resistance in Acute Heart Failure: A Single-Center Experience.	J Card Fail	2022
35939546	"Dip" in eGFR: Stay the Course With SGLT-2 Inhibition.	Circulation	2022
36139492	Diabetic Proteinuria Revisited: Updated Physiologic Perspectives.	Cells	2022
34862238	Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression.	J Am Soc Nephrol	2022
33200892	Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.	N Engl J Med	2021
36751533	Anti-Phospholipase A2 Receptor in Nonlupus Patients with Membranous Nephropathy and Crescents.	Glomerular Dis	2021
34152828	Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial.	Ann Intern Med	2021
33200891	Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.	N Engl J Med	2021
30635226	Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials.	Lancet Diabetes Endocrinol	2019
31338848	Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease.	Stat Med	2019
31023444	How Low Do We Go (in the Post-SPRINT Era)?	Adv Chronic Kidney Dis	2019
30623275	Correction to: Health care providers' support of patients' autonomy, phosphate medication adherence, race and gender in end-stage renal disease.	J Behav Med	2019
29162340	Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).	Am J Kidney Dis	2018
30105355	Treatment of Acute Intoxication From Inhaled 1,2-Difluoroethane.	Ann Intern Med	2018
30343731	Diabetic Kidney Disease: The Tiger May Have New Stripes.	Am J Kidney Dis	2018
29545381	Black Americans' Perspectives of Barriers and Facilitators of Community Screening for Kidney Disease.	Clin J Am Soc Nephrol	2018
29398179	Update on Diabetic Nephropathy: Core Curriculum 2018.	Am J Kidney Dis	2018
27615161	Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis.	Hemodial Int	2017
28128726	The safety of achieved iron stores and their effect on IV iron and ESA use: post-hoc results from a randomized trial of ferric citrate as a phosphate binder in dialysisâ¿©.	Clin Nephrol	2017
27647855	Anti-TGF-<i>Î²</i>1 Antibody Therapy in Patients with Diabetic Nephropathy.	J Am Soc Nephrol	2017
27167227	Health care providers' support of patients' autonomy, phosphate medication adherence, race and gender in end stage renal disease.	J Behav Med	2016
26362696	GFR Estimation Using Î²-Trace Protein and Î²2-Microglobulin inÂ CKD.	Am J Kidney Dis	2016
26553785	Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT.	J Am Soc Nephrol	2016
27663042	Non-GFR Determinants of Low-Molecular-Weight Serum ProteinÂ Filtration Markers in CKD.	Am J Kidney Dis	2016
25060056	Ferric citrate controls phosphorus and delivers iron in patients on dialysis.	J Am Soc Nephrol	2015
26271368	Government Quality Measures: First Do No Harm.	Semin Dial	2015
26421755	Opioid Use in Hemodialysis Patients.	Am J Kidney Dis	2015
26336594	Managing hyperphosphatemia in patients with chronic kidney disease on dialysis with ferric citrate: latest evidence and clinical usefulness.	Ther Adv Chronic Dis	2015
26085555	The effects of weight change on glomerular filtration rate.	Nephrol Dial Transplant	2015
26239948	Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data.	Drugs R D	2015
25912398	Self-Motivation Is Associated With Phosphorus Control in End-Stage Renal Disease.	J Ren Nutr	2015
25887072	Rebuttal of the Pro View: Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD.	Clin J Am Soc Nephrol	2015
25887070	Albuminuria is Not an Appropriate Therapeutic Target in Patients with CKD: The Con View.	Clin J Am Soc Nephrol	2015
25885460	Specialist and primary care physicians' views on barriers to adequate preparation of patients for renal replacement therapy: a qualitative study.	BMC Nephrol	2015
25987260	Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).	Am J Kidney Dis	2015
25958079	The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.	Am J Kidney Dis	2015
25736045	Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.	J Am Soc Nephrol	2015
25495878	Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costs.	Expert Rev Pharmacoecon Outcomes Res	2015
25532068	Pyridoxamine dihydrochloride in diabetic nephropathy (PIONEER-CSG-17): lessons learned from a pilot study.	Nephron	2015
24677717	Bilirubin and progression of nephropathy in type 2 diabetes: a post hoc analysis of RENAAL with independent replication in IDNT.	Diabetes	2014
25247329	Hypertension: is it time to reconsider blood pressure guidelines?	Nat Rev Nephrol	2014
24602469	Optimizing blood pressure control in patients with nondiabetic glomerular disease.	Adv Chronic Kidney Dis	2014
24721220	Guidelines and Straitjackets: blood pressure targets in the era of the Eighth Joint National Committee.	Am J Kidney Dis	2014
22702490	Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis.	Hemodial Int	2013
30731649	Ferric citrate: a novel phosphate-binding agent.	Expert Rev Endocrinol Metab	2013

1 - 50 of 170

Luis M Ortega

Alegheny General Hospital, Temple University School of Medicine

Career Start Year 2009

Number of shared co-authors 1

John Schollum

Dunedin School of Medicine, University of Otago

Career Start Year 2008

Number of shared co-authors 0

Nisha Bansal

Kidney Research Institute, University of Washington

Career Start Year 2003

Number of shared co-authors 12

Martin H de Borst

University Medical Center Groningen

Career Start Year 2003

Number of shared co-authors 3

Ian H de Boer

and the Kidney Research Institute, University of Washington

Career Start Year 2002

Number of shared co-authors 15

Bryan Kestenbaum

University of Washington

Career Start Year 2002

Number of shared co-authors 11

Mark S Segal

University of Florida

Career Start Year 2001

Number of shared co-authors 1

Heather N Reich

University Health Network and University of Toronto

Career Start Year 2000

Number of shared co-authors 1

Uptal D Patel

Duke University

Career Start Year 2000

Number of shared co-authors 5

Gearoid M McMahon

Brigham and Women's Hospital, MA Harvard Medical School

Career Start Year 1999

Number of shared co-authors 2

Joachim H Ix

University of California

Career Start Year 1999

Number of shared co-authors 10

Tara I Chang

Stanford University School of Medicine

Career Start Year 1999

Number of shared co-authors 9

Michael G Shlipak

University of California san francisco

Career Start Year 1999

Number of shared co-authors 10

Rajesh Mohandas

LSU Health New Orleans School of Medicine

Career Start Year 1999

Number of shared co-authors 0

Anitha Vijayan

Washington University in St. Louis.

Career Start Year 1998

Number of shared co-authors 3

Lynda A Szczech

FibroGen Inc.

Career Start Year 1997

Number of shared co-authors 0

Aldo J Peixoto

Universidade Federal Rural do Rio de Janeiro

Career Start Year 1996

Number of shared co-authors 2

Sushrut S Waikar

Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center

Career Start Year 1995

Number of shared co-authors 12

Abutaleb A Ejaz

University of Maryland School of Medicine

Career Start Year 1994

Number of shared co-authors 0

Andrew A House

The Lilibeth Caberto Kidney Clinical Research Unit, Western University

Career Start Year 1993

Number of shared co-authors 4

Robert J Walker

University of Otago

Career Start Year 1991

Number of shared co-authors 0

James A Tumlin

Emory University

Career Start Year 1990

Number of shared co-authors 3

Jonathan Himmelfarb

Kidney Research Institute and Division of Nephrology, University of Washington

Career Start Year 1990

Number of shared co-authors 14

Rakesh Malhotra

University of California San Diego

Career Start Year 1989

Number of shared co-authors 7

Somchai Eiam-Ong

Chulalongkorn University

Career Start Year 1988

Number of shared co-authors 0

Carsten A B??ger

Hospital Traunstein, University Hospital Regensburg

Career Start Year 1988

Number of shared co-authors 4

Mitchell H Rosner

University of Virginia Health

Career Start Year 1987

Number of shared co-authors 2

Claudine Jurkovitz

Christiana Care Health Services Inc.

Career Start Year 1987

Number of shared co-authors 3

Michael J Germain

Baystate Medical Center-University of Massachusetts Springfield

Career Start Year 1982

Number of shared co-authors 3

Vinod Bansal

Mayo Clinic

Career Start Year 1978

Number of shared co-authors 1

row(s) 1 - 30 of 30

Jamie P Dwyer

University of Utah Health

Co-authored papers 26

James P Lash

Co-authored papers 8

Talat Alp Ikizler

Vanderbilt University Medical Center

Co-authored papers 5

Jeffrey M Testani

Yale University School of Medicine

Co-authored papers 5

Josh F Peterson

Vanderbilt University Medical Center

Co-authored papers 5

Edward D Siew

Vanderbilt O'Brien Center for Kidney Disease, Vanderbilt University Medical Center

Co-authored papers 4

Deepak L Bhatt

Icahn School of Medicine at Mount Sinai Health System

Co-authored papers 4

Allison B McCoy

Vanderbilt University Medical Center

Co-authored papers 4

Josef Coresh

Co-authored papers 4

Christopher P Cannon

Brigham and Women's Hospital

Co-authored papers 4

Lemuel R Waitman

University of Missouri School of Medicine, PCORnet Clinical Research Network

Co-authored papers 4

Zachary L Cox

Department of Pharmacy Practice, Lipscomb University College of Pharmacy

Co-authored papers 3

Michel Komajda

Saint Joseph Hospital, Paris-Sorbonne University

Co-authored papers 3

Kenneth A Wallston

Vanderbilt University Medical Center

Co-authored papers 3

Rory Wolfe

Co-authored papers 3

Gautam Bhave

Center for Matrix Biology, Vanderbilt University Medical Center

Co-authored papers 3

Gerjan Navis

University Medical Center Groningen

Co-authored papers 3

Tazeen H Jafar

Co-authored papers 3

Renato D Lopes

Duke Clinical Research Institute, Duke University

Co-authored papers 3

Ioana Danciu

Oak Ridge National Laboratory

Co-authored papers 3

Michael Matheny

American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School

Co-authored papers 2

Neeraja B Peterson

Vanderbilt University Medical Center

Co-authored papers 2

Raymond C Harris

Vanderbilt University Medical Center

Co-authored papers 2

Juan Pablo Arroyo

National Research Council of Canada

Co-authored papers 2

Randolph A Miller

National Institutes of Health